{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:00:12Z","timestamp":1791824412348,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL082945"],"award-info":[{"award-number":["R01 HL082945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA108631"],"award-info":[{"award-number":["P01 CA108631"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1053\/j.seminoncol.2011.04.010","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T13:47:26Z","timestamp":1316785646000},"page":"621-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Molecular Dissection of the 5q Deletion in Myelodysplastic Syndrome"],"prefix":"10.1053","volume":"38","author":[{"given":"Benjamin L.","family":"Ebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2011.04.010_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1078-0432.CCR-05-1437","article-title":"Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies","volume":"12","author":"Giagounidis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10245330410001723824","article-title":"The 5q-syndrome","volume":"9","author":"Giagounidis","year":"2004","journal-title":"Hematology"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0609.1987.tb00777.x","article-title":"Specificity of haematological indicators for \u20185q-syndrome\u2019 in patients with myelodysplastic syndromes","volume":"39","author":"Teerenhovi","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(96)00350-0","article-title":"5q-, twenty-five years later: a synopsis","volume":"94","author":"Van den Berghe","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/251437a0","article-title":"Distinct haematological disorder with deletion of long arm of no. 5 chromosome","volume":"251","author":"Van den Berghe","year":"1974","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-4608(85)90016-0","article-title":"The 5q-anomaly","volume":"17","author":"Van den Berghe","year":"1985","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/leu.2009.53","article-title":"Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer","volume":"23","author":"Ebert","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/geno.1994.1090","article-title":"Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint","volume":"19","author":"Boultwood","year":"1994","journal-title":"Genomics"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib9","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1182\/blood.V99.12.4638","article-title":"Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome","volume":"99","author":"Boultwood","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib10","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1073\/pnas.92.16.7406","article-title":"Physical mapping of the minimal region of loss in 5q- chromosome","volume":"92","author":"Fairman","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/geno.2000.6414","article-title":"Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q)","volume":"71","author":"Lai","year":"2001","journal-title":"Genomics"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib12","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.94.13.6948","article-title":"Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map","volume":"94","author":"Zhao","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib13","first-page":"133","article-title":"The 5q-syndrome","volume":"142","author":"Giagounidis","year":"2008","journal-title":"Cancer Treat Res"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib14","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood.V81.4.1040.1040","article-title":"The 5q-syndrome: a single-institution study of 43 consecutive patients","volume":"81","author":"Mathew","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib15","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1200\/JCO.2005.03.6715","article-title":"Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q","volume":"24","author":"Nimer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","article-title":"A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome","volume":"16","author":"Barlow","year":"2009","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q-syndrome gene by RNA interference screen","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2007.06833.x","article-title":"Gene expression profiling of CD34+ cells in patients with the 5q-syndrome","volume":"139","author":"Boultwood","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0609.2010.01473.x","article-title":"Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion","volume":"85","author":"Oliva","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1182\/blood-2008-05-159707","article-title":"Lack of RPS14 promoter aberrant methylation supports the haploinsufficiency model for the 5q-syndrome","volume":"112","author":"Valencia","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/5951","article-title":"The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia","volume":"21","author":"Draptchinskaia","year":"1999","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib23","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1182\/blood-2009-10-178129","article-title":"Ribosomopathies: human disorders of ribosome dysfunction","volume":"115","author":"Narla","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/hmg\/ddn015","article-title":"Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder","volume":"17","author":"Choesmel","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/humu.20608","article-title":"Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia","volume":"28","author":"Cmejla","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib26","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood-2008-02-140012","article-title":"Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia","volume":"112","author":"Farrar","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/510020","article-title":"Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia","volume":"79","author":"Gazda","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib28","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood-2009-12-259705","article-title":"Induction of p53 and up-regulation of the p53 pathway in the human 5q-syndrome","volume":"115","author":"Pellagatti","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/ng.188","article-title":"Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects","volume":"40","author":"McGowan","year":"2008","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib30","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2010-07-295238","article-title":"Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells","volume":"117","author":"Dutt","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib31","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.947.947","article-title":"Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q-syndrome","volume":"114","author":"Kumar","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib33","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V96.6.2012","article-title":"Isolation and characterization of hematopoietic progenitor\/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level","volume":"96","author":"Nilsson","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib34","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2007-03-079368","article-title":"The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes","volume":"110","author":"Nilsson","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2008.01.015","article-title":"The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells","volume":"2","author":"Min","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2007-01-068809","article-title":"Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders","volume":"110","author":"Joslin","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib37","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2009-11-251835","article-title":"Haploinsufficiency of Apc leads to ineffective hematopoiesis","volume":"115","author":"Wang","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib38","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2009-11-251728","article-title":"The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD\/MDS","volume":"115","author":"Lane","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib39","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.leu.2404852","article-title":"Common deleted genes in the 5q-syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice","volume":"21","author":"Lehmann","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib40","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.0610477104","article-title":"Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients","volume":"104","author":"Pellagatti","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib41","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1038\/onc.2009.207","article-title":"5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics","volume":"28","author":"Eisenmann","year":"2009","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib42","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/leu.2010.105","article-title":"WHO-defined \u2018myelodysplastic syndrome with isolated del(5q)\u2019 in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations","volume":"24","author":"Patnaik","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib43","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature03915","article-title":"Role of nucleophosmin in embryonic development and tumorigenesis","volume":"437","author":"Grisendi","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nature04957","article-title":"The stem-cell niche as an entity of action","volume":"441","author":"Scadden","year":"2006","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.04.010_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","article-title":"A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome","volume":"16","author":"Barlow","year":"2010","journal-title":"Nat Med"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:53:24Z","timestamp":1758804804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775411001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0093775411001254"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2011.04.010","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Dissection of the 5q Deletion in Myelodysplastic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2011.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}